NCT06565637 Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
| NCT ID | NCT06565637 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Auburn University |
| Condition | Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 30 participants in total. It began in 2025-02-28 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a new intervention (Promoting Resilience to Improve Disordered Eating; PRIDE) can decrease internalized stigma and increase the ability to cope effectively with stressors in sexual minority populations diagnosed with eating disorders. The main question it aims to answer is: Will an eating disorders treatment focused on decreasing internalized stigma and increasing sexual minority stress coping self efficacy in sexual minority populations? Participants Will * Complete a telephone screen with study staff to determine preliminary eligibility for the study * Undergo a behavioral eligibility screening that includes structured clinical interviewing in order to determine proper diagnosis of an eating disorder along with ensuring absence of non-eating disorder diagnoses * Complete self-report measures to determine study eligibility * Attend up to 14 weekly therapy sessions as part of the PRIDE intervention, where participants will work with qualified clinicians to address eating pathology and disordered body image along with developing effective strategies for coping with sexual minority stressors * Complete surveys upon completion of the intervention 3 and 6 months post follow-up
Eligibility Criteria
Inclusion Criteria: * age 18 to 65 years * identify as lesbian, gay, bisexual, other non-heterosexual identities * meet criteria for a Diagnostic and Statistical Manual - 5 (DSM-5) eating disorder (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, other specified feeding or eating disorder) * reports current (past 12 months) experience with discrimination due to sexual orientation; * speaks English * has internet access and a working webcam * reside (and plan to continue to reside for the study duration) in California or one of the Psychology Interjurisdictional Compact (PSYPACT) states * able to provide informed consent Exclusion Criteria: * inability to speak/read English * active suicidal plans or intent * other major untreated psychiatric diagnoses (e.g., untreated bipolar disorder, untreated psychosis) * body mass index below 17.0, a standard clinical cutoff used to denote moderate-severe underweight that may be indicated for a higher level of medical care than standard outpatient treatment
Contact & Investigator
Tiffany Brown, PhD
PRINCIPAL INVESTIGATOR
Auburn University
Frequently Asked Questions
Who can join the NCT06565637 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06565637 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT06565637 currently recruiting?
Yes, NCT06565637 is actively recruiting participants. Contact the research team at tiffanybrown@auburn.edu for enrollment information.
Where is the NCT06565637 trial being conducted?
This trial is being conducted at Auburn, United States, San Diego, United States.
Who is sponsoring the NCT06565637 clinical trial?
NCT06565637 is sponsored by Auburn University. The principal investigator is Tiffany Brown, PhD at Auburn University. The trial plans to enroll 30 participants.